EWG Elevate’s Zimmer Biomet ZBH Stock Holding History

EWG Elevate’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5	Closed	-$638	–	820
2022 Q4	$638	Buy	+5	New	+$580	﹤0.01%	715

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EWG Elevate's ZBH Position: Q1 2023 in Review

EWG Elevate sold out of Zimmer Biomet (ZBH) in Q1 2023, closing a stake of 5 shares — an estimated $638 sold.

EWG Elevate first reported a position in ZBH in Q4 2022 and held it in 1 quarter. The position peaked at $638 in Q4 2022. 993 funds tracked by Wall St. Rank hold ZBH as of Q1 2023.

EWG Elevate reported no remaining Zimmer Biomet position as of Q1 2023 after selling out during the quarter.
EWG Elevate sold 5 Zimmer Biomet shares in Q1 2023, an estimated $638.
EWG Elevate first reported a position in Zimmer Biomet in Q4 2022 and held it in 1 quarter.
EWG Elevate's Zimmer Biomet position peaked at $638 in Q4 2022.
993 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2023.

Based on EWG Elevate's 13F filing for Q1 2023, filed 13 Apr 2023.